Dexcom is marking National Diabetes Awareness Month and World Diabetes Day in November with a new campaign asking people affected by diabetes to write a letter to the condition.
The “A Letter to Diabetes” campaign invites people around the world to “put into words everything they’ve wanted to say about their diabetes journey, from the heartfelt and humorous to the hopeful and unexpected,” Dexcom said in a Nov. 2 release.
The campaign invites people living with diabetes, their family members, caregivers and healthcare providers to share their experiences. Dexcom has also enlisted several people from the diabetes community to write their own letters as part of the campaign.
They include songwriter, actor and Beyond Type 1 co-founder Nick Jonas, who has worked with Dexcom for years and lives with type 1 diabetes.
“Diabetes, when we first met, your unpredictability threw me,” Jonas writes in his highly personal letter released by Dexcom. “I’d built my whole life around this unrealistic structure and belief that I was in control. You took that apart over the years, bit by bit. Part of me is grateful I learned that lesson. Part of me resents you for it. I never wanted to be a victim, or to come across like one.
“I share my story for the 13-year-old who just got diagnosed and is lying in a hospital bed, scared to death. I want them to see someone out there living their dreams while managing this, every single day.”
Dexcom has also tapped Chris Megino, who has built an online following sharing his journey with type 2 diabetes, and Chelsea Lugone, a nurse practitioner and diabetes care and education specialist at Dexcom.
Lugone also lives with type 1 diabetes and is the mother of two children who have the condition.
“Living with diabetes is one thing, but watching my children live with it is something entirely different,” she writes.
“For now, I will keep doing my best – for myself, for my children – leaning into our community and those who support us. I will continue to live the best life I can – reminding myself and others who are impacted by you that we are more than you – we are more than a number and we always will be.”
Dexcom, which has run a series of awareness campaigns over the years to coincide with National Diabetes Awareness Month and World Diabetes Day, markets Stelo, its over-the-counter glucose biosensor.
Stelo launched in the U.S. in 2024 following FDA clearance for adults who do not use insulin, including those with diabetes and people without the condition who want to better understand how diet and exercise affect their glucose levels.
Dexcom also sells its G7 continuous glucose monitoring (CGM) system for people with diabetes and competes with Abbott's FreeStyle products in the CGM market.